A Multidisciplinary Roadmap for an Oral Therapeutic to Neutralize Uremic Toxins in Chronic Kidney Disease
收藏资源简介:
Background: Chronic Kidney Disease (CKD) represents a profound global health challenge, affecting approximately 843 million individuals worldwide, with end-stage renal disease (ESRD) requiring dialysis in 3.9 million cases (GBD 2021) \cite{1}. The insidious accumulation of cytotoxic protein-bound uremic toxins (PBUTs) drives progressive renal deterioration and multisystemic comorbidities, while established renal replacement therapies like hemodialysis remain invasive, resource-constrained, and burdensome, highlighting unmet needs such as access disparities in low-income countries (WHO 2023) \cite{33}.Methods: This manuscript delineates a comprehensive translational framework for a pioneering oral therapeutic paradigm engineered to neutralize PBUTs via high-affinity competitive binding and augmented clearance mechanisms, potentially offering a viable alternative to dialysis. Harnessing AI-guided medicinal chemistry, advanced nanotechnology, and systems pharmacology, we propose a multi-component nanoparticle-encapsulated formulation to surmount gastrointestinal barriers and achieve targeted bioavailability.Results (Conceptual): Predictive modeling suggests a potential 40-60% reduction in PBUT levels based on rodent models, with enhanced eGFR preservation and mitigation of oxidative stress, supported by Monte Carlo sensitivity analyses demonstrating model robustness.Conclusions: This approach promises a paradigm-shifting, non-invasive, efficacious, and economically viable alternative to dialysis, poised to improve patient-centric outcomes including quality-adjusted life years (QALYs) and healthcare equity, with a call for collaborative preclinical validation.Word count: 350.Keywords: Chronic Kidney Disease, Protein-Bound Uremic Toxins, Competitive Displacement Neutralization, Oral Nanotherapeutics, AI-Optimized Medicinal Chemistry, Systems Pharmacology, Translational Roadmap, Kidney-Gut Axis, Enterohepatic Circulation, Non-Dialytic Clearance.



